Yusuke Goto

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 37

Top Topics

Editorial Comment

Prostate Cancer

Top Venues

International journal of urology : official journal of the Japanese Urological Association

IJU case reports

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Goto
Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries. International journal of urology : official journal of the Japanese Urological Association (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Yusuke Goto
Editorial Comment on Prostate cancer and liquid biopsies: Clinical applications and challenges. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Yusuke Goto
Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Yusuke Goto
Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Yusuke Goto
Editorial Comment on Japanese clinical practice guidelines for prostate cancer 2023. International journal of urology : official journal of the Japanese Urological Association (2024)
Yusuke Goto
Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Yusuke Goto
Editorial Comment on Prostate cancer and liquid biopsies: Clinical applications and challenges. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Yusuke Goto
Editorial Comment on Prostate cancer and liquid biopsies: Clinical applications and challenges. International journal of urology : official journal of the Japanese Urological Association (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Yusuke Goto
Editorial Comment on Prostate cancer and liquid biopsies: Clinical applications and challenges. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A kinome-wide synthetic lethal CRISPR/Cas9 screen reveals that mTOR inhibition prevents adaptive resistance to CDK4/CDK6 blockade in HNSCC. Cancer research communications (2024)
Shunichi Asai, Yusuke Goto, Kengo Tanigawa, Yuya Tomioka, Mayuko Kato, Keiko Mizuno, Shinichi Sakamoto, Naohiko Seki
MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3. FEBS letters (2023)
Yusuke Goto
Editorial Comment to Learning from the past and present to change the future: Endoscopic management of upper urinary tract urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association (2023)
Yusuke Goto
Editorial Comment to Stereotactic body radiation therapy for kidney cancer. Where do we stand? International journal of urology : official journal of the Japanese Urological Association (2023)
Jun Niino, Yusuke Goto, Tomokazu Sazuka, Hiroaki Sato, Takayuki Arai, Tomohiko Ichikawa
Off-clamp robot-assisted partial nephrectomy for renal hilar tumors. International journal of urology : official journal of the Japanese Urological Association (2023)
Yusuke Goto
Editorial Comment to Evaluation of sexual function after robot-assisted radical prostatectomy: A farewell to IIEF questionnaire. International journal of urology : official journal of the Japanese Urological Association (2023)
Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun-Ichiro Ikeda, Tomohiko Ichikawa
A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy. IJU case reports 6 (3) (2023)
Nobuyoshi Takeuchi, Yusuke Imamura, Kazuki Ishiwata, Manato Kanesaka, Yusuke Goto, Tomokazu Sazuka, Sawako Suzuki, Hisashi Koide, Shinichi Sakamoto, Tomohiko Ichikawa
Cushing's syndrome in pregnancy in which laparoscopic adrenalectomy was safely performed by a retroperitoneal approach. IJU case reports 6 (6) (2023)
Satoki Tanaka, Yusuke Goto, Ayumi Fujimoto, Takayuki Arai, Hiroaki Sato, Tomokazu Sazuka, Yusuke Imamura, Shinichi Sakamoto, Jun-Ichiro Ikeda, Tomohiko Ichikawa
A case of ipsilateral three simultaneous renal cell carcinomas with different histologic types. IJU case reports 6 (6) (2023)
Ryo Tsukamoto, Tomokazu Sazuka, Yoshinori Hattori, Hiroaki Sato, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Tomohiko Ichikawa
Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data. Cancers 15 (6) (2023)
Shunichi Asai, Yusuke Goto, Kengo Tanigawa, Yuya Tomioka, Mayuko Kato, Keiko Mizuno, Shinichi Sakamoto, Naohiko Seki
MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3. FEBS letters (2023)
Yutaro Arai, Yusuke Goto, Tomokazu Sazuka, Ayumi Fujimoto, Hiroaki Sato, Yusuke Imamura, Shinichi Sakamoto, Masayuki Ota, Jun-Ichiro Ikeda, Tomohiko Ichikawa
A case of bladder cancer after bilateral lung transplantation following bone marrow transplantation. IJU case reports 6 (6) (2023)
Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu, Masahiro Shinmura, Shunsuke Misono, Yusuke Goto, Naoko Kikkawa, Mayuko Kato, Hiromasa Inoue, Keiko Mizuno, Naohiko Seki
Identification of Tumor-Suppressive miR-139-3p- Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers 15 (23) (2023)
Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun-Ichiro Ikeda, Tomohiko Ichikawa
A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy. IJU case reports 6 (3) (2023)
Yusuke Goto
Editorial Comment on Urinary markers for bladder cancer diagnosis: A review of current status and future challenges. International journal of urology : official journal of the Japanese Urological Association (2023)
Ryo Tsukamoto, Tomokazu Sazuka, Yoshinori Hattori, Hiroaki Sato, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Tomohiko Ichikawa
Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data. Cancers 15 (6) (2023)
Yusuke Goto, Takanobu Utsumi, Masafumi Maruo, Akira Kurozumi, Takahide Noro, Satoki Tanaka, Sho Sugawara, Kazuto Chiba, Kanetaka Miyazaki, Atsushi Inoue, Atsushi Komaru, Satoshi Fukasawa, Yusuke Imamura, Shinichi Sakamoto, Hiroomi Nakatsu, Hiroyoshi Suzuki, Tomohiko Ichikawa, Maki Nagata
Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era. International journal of urology : official journal of the Japanese Urological Association (2023)
Yusuke Goto
Editorial Comment to Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated disease. International journal of urology : official journal of the Japanese Urological Association (2023)
Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun-Ichiro Ikeda, Tomohiko Ichikawa
A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy. IJU case reports 6 (3) (2023)
Yusuke Goto, Satoki Tanaka, Masafumi Maruo, Sho Sugawara, Kazuto Chiba, Kanetaka Miyazaki, Atsushi Inoue, Tomohiko Ichikawa, Maki Nagata
Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis. IJU case reports 5 (4) (2022)
Yusuke Goto
Editorial comment to real-world outcomes of pembrolizumab for platinum refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial-unfit patients. International journal of urology : official journal of the Japanese Urological Association (2022)
Ryutaro Yasudome, Naohiko Seki, Shunichi Asai, Yusuke Goto, Yoshiaki Kita, Yuto Hozaka, Masumi Wada, Kan Tanabe, Tetsuya Idichi, Shinichiro Mori, Takao Ohtsuka
Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive miR-139-3p . International journal of molecular sciences 23 (19) (2022)
Yusuke Goto
Editorial Comment to miRNAs in prostate cancer: Intercellular and extracellular communications. International journal of urology : official journal of the Japanese Urological Association (2022)
Yusuke Goto
Editorial Comment to Trends in primary treatment for localized prostate cancer according to the availability of treatment modalities and the impact of introducing robotic surgery. International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)